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Abstract: Worldwide approximately two billion people have a diet insufficient in 
micronutrients. Even in the developed world, an increasing number of people consume 
nutrient-poor food on a regular basis. Recent surveys in Western countries consistently 
indicate inadequate intake of nutrients such as vitamins and minerals, compared to 
recommendations. The International Osteoporosis Foundation’s (IOF) latest figures show 
that globally about 88% of the population does not have an optimal vitamin D status.  
The Lancet’s “Global Burden of Disease Study 2010” demonstrates a continued growth in 
life expectancy for populations around the world; however, the last decade of life is often 
disabled by the burden of partly preventable health issues. Compelling evidence suggests 
that improving nutrition protects health, prevents disability, boosts economic productivity 
and saves lives. Investments to improve nutrition make a positive contribution to long-term 
national and global health, economic productivity and stability, and societal resilience. 
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1. Introduction 
According to the World Health Organization (WHO), in the majority of countries, the proportion of 
people aged over 60 years is growing faster than any other age group, as a result of longer life expectancy 
and declining fertility rates. Consequently, from 2000 until 2050, the proportion of the global population 
over 60 years will double from ca. 11% to 22% [1]. This can be interpreted as a success story for public 
health policies and for socioeconomic development, but at the same time it also challenges societies to 
adapt and overcome the health and economic burden of ageing and age-related conditions. Healthy 
ageing is key if older people are to remain independent and to play an integral part in society. (“Healthy” 
refers to physical, mental, and social wellbeing as indicated in the WHO definition of health.) Life-long 
health promotion, with a clear emphasis on the fundamental role of nutrition and micronutrients to reduce 
risks of chronic conditions and disability, may prevent or delay the onset of several non-communicable 
diseases. One example for such an initiative in the European Union is the European Innovation 
Partnership on Active and Healthy Ageing, which aims to increase the average healthy lifespan by two 
years by 2020 [2].  
In the long-term, inadequate micronutrient intake can lead to chronic micronutrient undernutrition 
and consequent health problems, including lower resistance to development of chronic disease thus 
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reducing health span and longevity. Micronutrient deficiencies (MNDs) are well established in the 
developing world, however, a growing body of evidence shows the existence of MNDs also in the 
developed world [3]. The term ‘hidden hunger’ is commonly used in this context, as these deficiencies 
are often ignored and underestimated despite the serious consequences they can hold for individuals, 
communities, and national economies. MNDs are particularly harmful during pregnancy and early 
childhood due to their impact on the physical and cognitive development of children. Micronutrient 
requirements also have to be adjusted later in life, for example to the specific micronutrient requirements 
of the elderly and those living in particular settings such as hospitals and institutions.  
Scientists, clinicians, and public health specialists met at the European Research Institute for the 
Biology of Ageing (University Medical Center Groningen, The Netherlands), in a workshop to address 
topics related to the contribution of nutrients to healthy ageing, the impact of nutritional approaches in 
health and disease and solutions on healthy ageing, and the implications of optimal nutrient intake over 
the life course on healthcare-related costs including possible economic benefits. The workshop covered 
a wide range of topics, from health economics of disease-related malnutrition through healthy ageing 
during the course of life to health and economic benefits of fortification or supplementation with certain 
nutrients. A roadmap has been proposed to address pending issues that must contribute to reduction of 
health care costs. 
2. Health Economics of Malnutrition 
There are several definitions of malnutrition. An international acknowledged definition is “A state of 
nutrition in which a deficiency, excess or imbalance of energy, protein, and other nutrients causes 
measurable adverse effects on tissue/body form (body shape, size and composition) function, and clinical 
outcome” [4]. Malnutrition thus includes both overnutrition (too many nutrients) and undernutrition 
(insufficient nutrition). In this manuscript, malnutrition refers to undernutrition. Furthermore, there are 
several causes for malnourishment. Depending on the cause, one can talk about disease-related 
malnutrition, wasting, sarcopenia or nutrient depletion like MND [5].  
2.1. Measuring the Impact of Malnutrition 
Measuring the effects of malnutrition is important to assess the burden of disease in populations, to 
analyze trends and progress over time, and to compare countries, regions and social groups. It is also 
vital as a priority-setting tool for policy makers. The global consensus recognizing the value of 
appropriate nutrient intake is based on a solid body of evidence and on a number of powerful nutritional 
and economic models. Examples of health economic evaluations are cost-utility analyses in which the 
values are expressed as Quality-Adjusted Life Years (QALYs) and Disability Adjusted Life Years 
(DALYs). These analyses attach utility weights, so that morbidity and mortality can be combined in a 
common metric. These are particularly useful for making comparisons across health care interventions 
and disease domains. QALYs combine quantity and quality of life in a single index: One year of  
life × 1 utility value = 1 QALY. The utility for perfect health = 1, the utility for death = 0. The utility 
weights underpinning the QALY are based in part on subjective assessment or individual preferences. 
This subjective assessment of quality of life is sometimes referred to as “utility”. Already in 2006, the 
National Institute for Health and Clinical Excellence (NICE) developed a model to estimate the 
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incremental cost/QALY for nutritional screening and management of undernutrition by oral nutritional 
supplements compared to the situation where no such program would be in place for the elderly, resulting 
in £6800/QALY. As a threshold of £20–30,000/QALY is used by NICE for considering treatments to 
be cost-effective, screening and management of undernutrition can therefore be considered as value for 
money [6].  
The DALY measures burden of disease, indicating how many years of healthy life are lost due to  
no-fatal illness or impairment or death. The DALY also reflects the number of individuals that are ill or 
die in each age-sex group and location in a certain population. Where YYL = years of life lost due to 
premature mortality in the population (number of deaths multiplied by standard life expectancy at age 
of death in years) and YLD = years lost due to disability (number of disability cases multiplied by the average 
duration of disability weighted by the severity of a particular disease), then DALY = YYL + YLD. DALYs 
are based on egalitarian principles: the same life expectancy and disability weights are used regardless 
of geography, gender, and race. DALYs form the basis of WHO’s Burden of Disease concept, as they 
offer a comprehensive and comparable assessment of mortality and loss of health due to diseases, 
injuries, and risk factors for all regions of the world. DALYs have provided a powerful tool to measure 
and track the contribution of nutritional deficiencies to health—which is critical to raise awareness. 
Using this for policy making and priority setting presents a number of important challenges. 
DALYs and QALYs are examples for measuring effectiveness and subsequently cost-effectiveness 
of specific policies and/or interventions for policy making and priority setting, showing the efficiency 
across different age and sex groups. For example, they can be used in assessing the cost-effectiveness of 
mandatory food fortification with folic acid. In a recent study, mandatory fortification with folic acid 
was found to be cost-effective in Australia [7]. The cost-effectiveness evaluations of specific policies 
have been successful in solving the virtual elimination of goiter through salt iodization and the 
improvement of life expectancy of patients with metabolic disorders by ready-to-use therapeutic foods. 
However, there have also been limited successes in programs aiming at prevention of stunting, anemia, 
obesity, and associated co-morbidities. Failures have been partly due to the oversimplification of 
complex problems. Although needed, complex solutions may not rank high in current cost effectiveness 
analyses. There needs to be caution against generalization, and it is important to strengthen methods and 
models to fit the needs of complex nutritional problems. Early investments are necessary for long-term 
gains: this has been recognized in many social protection programs. Improvements in nutrition require 
strong efforts to change behavior by education and not just by providing a cost-effective product.  
2.2. The Global Impact of Inadequate Micronutrient Intake 
Inadequate micronutrient intake can have serious health consequences for individuals, but also has a 
wider impact on societies, economies, and healthcare and welfare systems. A recent publication 
demonstrates that the use of specific dietary supplements among those consumers that are at a high risk 
of experiencing a costly disease-related event can lead to healthcare cost savings. For example, the total 
cumulative direct healthcare costs related to osteoporosis-attributed bone fractures among all  
US women over the age of 55 diagnosed with osteoporosis is expected to be nearly $136 billion  
from 2013 to 2020. An average of $1.87 billion per year and a cumulative savings of $15 billion  
from 2013 to 2020 in avoidable hospital utilization costs is potentially realizable if all US women over 
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the age of 55 diagnosed with osteoporosis were to use calcium and vitamin D dietary supplements at 
preventive daily intake levels [8].  
It is widely recognized that MNDs are a significant public health problem. For example, globally one 
in two pre-school children suffers from anemia, many of them because of iron deficiency. Furthermore, 
about 190 million pre-school children suffer from vitamin A deficiency, but deficiencies in iodine, folate, 
and zinc are also highly prevalent. Wieser et al. carried out a burden of disease study, building a model 
of the lifetime consequences of micronutrient deficiencies and applying it to the Philippines. The study 
used data from two major surveys carried out in 2008: The Demographics and Health Survey (DHS) by 
the Philippines National Statistics Office (12,469 households) and the National Nutrition Survey (NNS) 
by the Philippines Food and Nutrition Research Institute (FNRI) (36,634 households). The population 
was classified into 10 socio–economic strata and two age groups per strata (children aged 6–23 and  
24–59 months). Prevalence of MNDs was based on hemoglobin, serum retinol, and serum zinc levels 
assessed in the NNS. Different health consequences of deficiencies (iron, vitamin A, and zinc) were 
examined: mortality, morbidity, and limitation of physical and cognitive development. The study also 
looked at direct medical costs, short- and long-term production losses and intangible costs such as 
number of life years lost and quality of life lost. The time dimension was the lifetime costs of a 1-year 
cohort. The results showed that total lifetime costs amounted to medical costs of US $29 million, 
production losses of US $462 million and intangible costs of 116,656 DALYs. Costs are dominated by 
future lifetime costs due to impaired mental and physical development and costs of premature deaths 
over current losses. Costs are substantially higher in the 6–23 months age group. There are considerable 
differences between socioeconomic groups, with the potential revenues in the poorest decile of 
households being five times higher than in the wealthiest decile. Costs are much higher for vitamin A 
and iron deficiency than for zinc deficiency, with the exception of direct medical costs. Significantly, 
83% of DALY losses and nearly all production losses due to iron deficiency occur in future lifetime. 
Without specific knowledge, therefore, parents may have no immediate reason to improve the diet of the 
child. The study concludes that policies aimed at reducing MNDs in children living in poor households 
should take account of the informational, behavioral, and economic obstacles. The high prevalence of 
MNDs in lower socio-economic strata may be one of the factors leading to a health-based poverty trap. 
Due to the impact of MNDs on physical and cognitive development, many children will not be able to 
reach their full potential and will become poor parents in their later life. The initiative “Fighting the 
malnutrition battle: the power of partnerships”, implemented by the Irish Society for Clinical Nutrition 
and Metabolism (IrSPEN) is a good example for the collaboration between academy, health care system, 
and industry partners. IrSPEN has managed to make rapid progress in its efforts to build a solid evidence 
base, increase malnutrition awareness, introduce nutrition training into post graduate medical education, 
and secure access to nutrition support for community patients (Figure 1) [9]. This approach can be 
adapted and used by other countries as well. 
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Figure 1. Irish Society for Clinical Nutrition and Metabolism (IrSPEN) adopted a highly 
focused strategy, drawing on ‘best practice’ examples, adapting and localizing key 
initiatives, and developing collaborations and partnerships to extend its sphere of influence. 
 
3. Healthy Ageing during Life Course 
3.1. Translating Scientific Knowledge into Public Health Solutions 
The European Commission’s European Innovation Partnership on Active and Healthy Ageing 
(http://ec.europa.eu/active-healthy-ageing) has been established to take the challenges of an ageing 
population and the associated challenges like lifestyle-related diseases, health workforce shortages, and 
the financial sustainability of health systems. The Partnership is part of the Innovation Union flagship 
initiative of the Europe 2020 strategy.  
The healthcare policy of the European Commission is based on the Lisbon Treaty’s Article 168, which 
calls for ‘The attainment of a higher level of health protection through all European policies and 
activities’ and encourages cooperation between member states. The EU complements national policies 
towards improving public health, preventing physical and mental diseases, and promoting research, as 
well as information and education and monitoring and combating serious cross-border health threats. It 
also adopts a legislation to meet common safety concerns related to human components, the veterinary 
and phyto-sanitary fields and medical products and devices. Before discussing in more detail the 
European Innovation Partnership on Active and healthy Ageing, the EU health strategy in general, and 
the EU Platform for action on Diet, Physical activity, and health will be briefly discussed. 
The EU Health Strategy “Together for health” (http://ec.europa.eu/health/strategy/policy/ 
index_en.htm) supports the overall Europe 2020 strategy. It is an overarching policy framework 
designed to work towards good health in an ageing Europe, protecting citizens from health threats and 
supporting dynamic health systems and new technologies through legislation, cooperation, and 
financing. The Strategy for Europe on Nutrition, Overweight, and Obesity-related health issues 
(http://ec.europa.eu/health/nutrition_physical_activity/policy/strategy_en.htm) calls for action in six 
priority areas: 1. Better-informed consumers; 2. Making the healthy option available; 3. Encouraging 
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physical activity; 4. Developing the evidence base to support policymaking; 5. Developing monitoring 
systems; 6. Putting children and low socio-economic groups as a priority.  
The EU Platform for action on Diet, Physical Activity and Health (http://ec.europa.eu/health/ 
nutrition_physical_activity/platform/index_en.htm) is a forum for European-level umbrella 
organizations, ranging from the food industry to consumer protection non-governmental organizations 
(NGOs). Its objective is to tackle current trends in diet and physical activity.  
Europe 2020 is the EU’s inclusive growth strategy. To implement this strategy, Europe has identified 
the so-called flagship initiatives, including the Innovation Union flagship initiative. The European 
Innovation Partnership on Active and Healthy Ageing (EIP on AHA) is part of the Innovation Union 
flagship initiative and is a new method of collaboration that is focused on active and healthy ageing. The 
European Commission recognizes the challenge of the demographic change of an ageing society and the 
challenges this presents to society and economy. Total age-related spending (on education, pensions, 
healthcare, and unemployment benefits) is expected to increase by 4.75% points of Gross Domestic 
Product (GDP) by 2060. There is also a shrinking workforce in the care sector and an insufficient number 
of health professionals. 
The goal of the European Innovation Partnership on Active and Healthy Ageing is to add on average 
two healthy life years by 2020. In a broader sense, the EIP on AHA pursues a triple win for Europe by 
improving the health and quality of life of European citizens with particular focus on older people, 
improving the long-term sustainability and efficiency of health and social care systems and enhancing 
the competitiveness of the EU-industry through business and expansion of new markets. It aims to 
achieve this through innovative collaboration through crosscutting, connecting, and engaging 
stakeholders across sectors, from the private and public sectors. It has established Action Groups (active 
partners working together towards a specific goal). Furthermore, there are Reference Sites, which 
provide the EIP on AHA with already implemented examples of a comprehensive, innovation-based 
approach to active and healthy ageing. These sites can be coalitions of regions, cities, integrated hospitals 
or care organizations that are able to show their impact and show particular innovative practices which 
could be transferred to other European contexts. Also a marketplace for innovative ideas (online 
collaboration, open to everybody) has been launched. One of the Action Groups is on the Prevention of 
Functional Decline and Frailty (http://ec.europa.eu/research/innovation-union/index_en.cfm?section= 
active-healthy-ageing&pg=action_group_a3). This Action Group defined a number of deliverables: to 
manage functional decline and frailty through targeted intervention, to enhance participation and 
independence (public awareness materials, events and an interactive website), to promote systematic 
routine screening for frailty, to establish integrated pathways of care, to pursue research and 
methodology (to determine the effects of a healthy diet and to develop new nutritional supplements) and 
to manage demand. 
3.2. The Importance of Micronutrient Intake in the First 1000 Days of Life 
While micronutrient requirements vary with the different stages of life, micronutrient status has the 
greatest impact during the first 1000 days. This is because of the rapid growth, tissue and organ 
differentiation during this period of life, leading to very high nutrient needs per kg of bodyweight, while 
body stores are low and several gastrointestinal, metabolic, and renal functions related to nutrient 
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turnover are still immature. The nutritional intake at this stage effects life-long health and has a major 
impact on short- and long-term outcomes [10]. The concept of metabolic programming was established 
almost four decades ago by Günther Dörner, who stated: ‘The concentrations of hormones, metabolites 
and neurotransmitters during critical early periods of development are capable of pre-programming brain 
development, functional disturbances and diseases as well as syndromes of reproduction and metabolism 
in human adulthood [11]. 
A recent systematic review and meta-analysis on poor vitamin D status in pregnancy has found that 
a low serum 25(OH)D level is independently associated with risk for gestational diabetes (pooled  
OR = 1.49), pre-eclampsia (1.79) and Small for Gestational Age (SGA) births: (1.85) [12]. In order to 
prevent birth defects, mandatory fortification of staple food with folic acid is currently applied in  
58 countries. In “new Europe”, Kosovo has already started and Moldova is working on legislations to 
start fortification. Lately, a very large cohort study in Norway found maternal intake of folic acid  
before and during early pregnancy to be associated with a significantly reduced incidence of  
specialist-diagnosed autistic disorders (0.10% in children whose mothers took folic acid, 0.21% in those 
unexposed, adj. OR = 0.61) [13]. Micronutrients are essential for brain growth and MNDs cause a 
reduced cognitive outcome: stunted children have been shown to have a lower intelligence quotient (IQ) 
than non-stunted children [14]. Early iron deficiency alters the metabolism in the hippocampus and 
striatum, with lasting effects on monoamines (DA, 5–HT, NE), myelin proteins, and compaction. This 
can lead to long-term behavioral changes. A study into school progress in former iron-deficient children 
in Costa Rica at age 11–14 years shows that significantly more children who were previously  
iron-deficient are referred for special services or repeat a grade [15]. According to the European health 
claims for docosahexaenoic acid (DHA), maternal DHA intake contributes to the normal brain 
development and the development of the eye of the fetus and breastfed infants [16]. Further studies found 
pre- and postnatal fish and DHA intake to predict an improved IQ at school age [17]. Higher cord blood 
DHA was linked to less behavioral problems at 10 years [18] and its supply during pregnancy also 
modulated the infant’s immune response [19] and reduced infectious diseases in infants [20]. 
Breastfeeding, which provides preformed long-chain polyunsaturated fatty acid (LC-PUFA), is 
recommended as the optimal feeding choice for infants [21]. For infants that are not breastfed, a 
calculation of cost-effectiveness of standard and LC-PUFA enriched formula on QALYs and costs 
showed that LC-PUFA supplementation of infant formula represents an economically worthwhile 
prevention strategy, even if it is only based on the costs derived from hypertension-linked diseases in 
later life [22].  
As late intervention may only have limited benefits, it is vital to optimize early nutrition for  
long-term health [23]. An adequate supply of critical nutrients (including Fe, Zn, I, folate, vitamin B12, 
vitamin A, vitamin D, and DHA) is essential before/throughout pregnancy and during lactation/infancy 
and early childhood. 
3.3. Undernutrition in the Elderly 
Average life expectancy has risen globally since 1950, currently reaching 57 years in Africa,  
70 years in Latin America, 79 years in North America and 78 years in Europe. A geriatric population 
has several nutrition issues, from unintentional weight loss through poor appetite to malnutrition. It is 
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reported that among those of 71 years or above, recommended intakes for fruits, vegetables, and whole 
grains are not met by around 70%, more than 80%, and more than 90%, respectively [24]. The prevalence 
of undernutrition changes from the age of 65 to 85 from 3.3% (in patients and healthy individuals), 7.8% 
(in patients in GP) and 33.8% (in home care patients) to 20.9%, 22.8%, and 32.8%, respectively [25]. As 
many as one in three older adults living independently are at risk of becoming undernourished [26]. A 
recent study found that 67% of patients in a European elderly care rehabilitation facility had a severe 
deficiency in 25(OH)D levels (below 10 ng/mL) [27].  
The effects of undernutrition on the elderly are significant: increased hospital stays, increased risk of 
non-elective re-admission, higher incidence of complications (delirium, infections, pressure sores), 
impaired functional status and decreased muscle function [28]. In adult hospital patients, decreased 
hand-grip strength is a predictor of loss of functional (muscle) status [29]. Reduced muscle strength and 
fatigue can lead to falls, reduced ability to self-care, poor recovery from chest infection [30], and 
impaired mobility [31]. There are higher hospitalization rates, higher nursing home placement rates, a 
reduced quality of life and increased mortality. Disease-related malnutrition has been found to double 
the risk of mortality in hospital patients and to triple mortality in older patients in hospital and after 
discharge [32]. Older women with weight loss have increased rates of hipbone density loss, and the risk 
of subsequent hip fracture is doubled [33]. A Dutch study in undernourished elderly patients 
demonstrated that short-term nutritional intervention (energy- and protein-enriched diet, oral nutritional 
supplements, calcium-vitamin D supplement, telephone counseling by a dietitian), decreased the number 
of fall incidents [34]. The clinical criteria for frailty (unintentional weight loss/sarcopenia, weakness, 
poor endurance, and low activity) are associated with chronic undernutrition resulting in loss of weight 
and muscle mass and poor muscle function [35]. Without appropriate intervention, frail older people are 
likely to experience functional limitations and disability, increased morbidity and use of healthcare 
resources, and mortality. It was estimated that in the UK more than half of the expenditure on undernutrition 
goes to people aged ≥65 years of age, who account for only about 15% of the population [30]. Comparative 
calculations in other countries confirmed the higher costs in elderly. For example in The Netherlands, 
the total additional costs of disease-related malnutrition were about four times higher for patients of  
at least 60 years of age (€1.5 billion) than for patients in the age category of >18 and <60 years  
(€403 million) [36].  
Malnutrition and/or weight loss in the elderly are cited as predictive variables for Clostridium difficile 
enterocolitis, postoperative pneumonia, intravascular device infection, catheter-associated urinary tract 
infection, and decubitus ulcer [37]. Yet, undernutrition in the elderly has no quantitative diagnosis, has 
no formal definition and is not recognized as a serious condition with major clinical and economic 
consequences. Comprehensive geriatric assessment including screening for malnutrition increases 
patients’ likelihood of surviving and returning to their own homes after an emergency admission to 
hospital [38]. Risk factor intervention strategies have demonstrated to result in significant reductions in 
the number and duration of episodes of delirium in hospitalized older patients [39]. More studies are 
needed, with multifaceted interventions, addressing the causes and risk factors as well as contributions 
of nutritional deficiencies [40]. To help combat this problem, it is recommended to adjust the nutrient 
density of the elderly diet according to the individual nutritional needs and intakes. Although ideally this 
would be achieved through a careful selection of a diverse daily nutrition intake, appropriate fortified 
foods and dietary supplements might prove to be a more promising approach. Given the magnitude of 
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the problem, it is imperative to find ways [9] to close the gap between recommended and actual nutrients 
intakes in the elderly [41].  
4. Established Evidence of Health and Economic Benefits of Selected Nutrients 
The health and economic benefits of fortification or supplementation with certain micronutrients has 
been shown in many studies. Several countries have already implemented mandatory fortification 
programs with micronutrients. Health care costs can be reduced through fortification with e.g., folate. 
Folate plays a key role in DNA synthesis and delivering methyl groups. Both mechanisms are highly 
active during pregnancy and early embryogenesis, therefore folate deficiency during pregnancy is 
causally related to several developmental abnormalities. Neural tube defects (NTDs) are among the most 
common birth defects, with a huge and long-term social and economic burden. Since the closure of the 
neural tube takes place in the first few weeks after conception, an optimal folate status should be 
achieved before that time. Early supplementation with folic acid can prevent up to 70% of all  
NTDs [42], depending on baseline serum folate, the dose of folic acid supplemented and the time 
window available for prevention [43]. Folate has also been shown to prevent other birth defects  
or adverse birth outcomes such as congenital heart defects [44], orofacial clefts [45], low birth  
weight [46], and preterm births [47]. Women planning for pregnancy are recommended to take  
0.4–0.8 mg folate/day starting at least 4 weeks before conception. Awareness and information campaigns 
that aimed at promoting folate usage among young women, increased the population awareness, but did 
not significantly affect practicing supplementation, neither were they effective in rising serum folate in 
the target group. Factors related to women’s age, education, and socioeconomic status limited the 
success of such campaigns in Canada [48]. The fortification with folate has been shown to improve 
folate status in the general population [49], to lower the incidence of NTDs, to be cost-effective [50], and 
safe for the population [51,52]. Low folate status is common in elderly people [53] and this was corrected 
in countries applying fortification (Figure 2) [54]. Higher folate status has been shown to protect against 
several age-associated diseases like coronary heart disease and cancer [53]. Mean dietary folate intake 
in Europe (180–250 μg/day) [55] does not provide sufficient protection against neural tube defects [56]. 
Effective national strategies, cooperation between the health system sectors, and legislations are needed 
in order to improve folate status of young women before conception. 
Vitamin D insufficiency alone is potentially associated with a wide variety of diseases, i.e., diseases 
of the musculo-skeletal system (associated with increased falls and fractures), immune system 
(associated with infections, allergies and tumors), endocrine system (associated with Type I and  
Type II diabetes), circulatory system (associated with hypertension, stroke, heart attack, and heart 
failure), and diseases of the nervous system (associated with multiple sclerosis, depression, and Alzheimer’s 
disease) [57]. The European Society for Clinical and Economic Aspects of Osteoporosis and 
Osteoarthritis (ESCEO) convened a meeting to provide recommendations for clinical practice, to ensure 
the optimal management of elderly and postmenopausal women with regard to vitamin D supplementation. 
Finding that patients with reduced vitamin D levels have increased bone turnover, bone loss, and possible 
mineralization defects, the ESCEO recommended supplementation of 800 to 1000 IU/day of vitamin D 
when the serum level is below 50 nmol/L. The same society has also advised that this threshold should 
be higher (75 nmol/L) for fragile, elderly subjects who are at increased risk of falls and fracture [58]. 
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Furthermore, data from a recent meta-analysis suggest a nonlinear decrease in mortality risk as 
circulating 25(OH)D increases, with optimal concentrations of approximately 75–87.5 nmol/L [59]. A 
recent study shows that, especially for France and Sweden, the societal burden of hip fractures associated 
with low calcium intake is quite substantial. This study calculated that the yearly number of DALYs lost 
was 6263 for France, 1246 for Sweden, and 374 for The Netherlands. The corresponding total costs that 
might potentially be avoided are about 129 million, 34 million, and 6 million Euros, in these countries, 
respectively [60]. More models for assessing and calculating costs related to inadequate nutrition as well 
as the assessment of the efficiency of nutritional programs are necessary. 
Figure 2. Grain Fortification Legislation—Countries in blue require fortification of wheat 
flour, maize flour, and/or rice (November 2013. Source: Flour Fortification Initiative). 
  
5. Pertinent Considerations in Providing Nutritional Solutions 
5.1. Disease-Related Malnutrition and the Economic Value of Medical Nutrition 
Disease-related malnutrition affects 33 million people in Europe and costs the European healthcare 
system €170 billion per year [61]. According to Eurostat (2010), there are 500 million people in Europe, 
with a GDP of €12.279 trillion, the total expenditure on health is approximately 10.4% of the GDP, or 
€1.28 trillion. In the management of malnutrition, early identification is key and screening should be 
routine practice [4]. Food for Special Medical Purposes (FSMP), also known as medical nutrition (or 
clinical nutrition), is a range of innovative nutritional products to be used under medical supervision and 
underpinned by scientific research. The nutrition administered is of unique compositions of specific 
nutrients, in formats and compositions to meet specific needs and administered enterally, which includes 
oral nutritional supplements as well as enteral tube feeding. In Europe, medical nutrition products are 
regulated by the Commission Directive 1999/21/EC on dietary foods for special medical purposes. 
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FSMP has demonstrated to have nutritional, clinical, and functional as well as economic benefits. For 
example, in the Netherlands the total additional costs of managing adult patients with disease-related 
malnutrition were estimated to be €1.9 billion in 2011, which equals 2.1% of the total national health 
expenditure [36]. A health economic analysis assessing the cost-effectiveness of oral nutritional 
supplements in undernourished Dutch abdominal surgery patients showed that using oral nutritional 
supplements resulted in a €252 (7.6%) cost saving per patient, leading to an annual costs saving of at 
least €40.4 million per year. These costs savings were due to a reduction in hospitalization costs from 
€3318 to €3044 per patient and corresponds with 0.72 days reduction in length of stay. [62]. Another 
medical nutrition economic study on oral nutritional supplements in the Netherlands demonstrated a cost 
saving of €12,986 million (4.7% savings) in community dwelling for elderly patients suffering from 
disease-related malnutrition. The additional costs of oral nutritional supplements (€57 million) were 
more than balanced by the reduction in the total costs of disease-related malnutrition due to a reduction 
of re-/hospitalization (€70 million) [63]. Similar financial benefits of oral nutritional supplements in 
hospital have been demonstrated in Denmark and other European countries [64]. According to a recently 
published eleven-year retrospective (2000 to 2010) study in the US, the use of oral nutritional 
supplements decreases length of stay, episode cost, and 30-day readmission risk in the inpatient 
population [65]. These findings were confirmed by two recent systematic reviews stating that the use of 
FSMP in the management of disease-related malnutrition, for inpatients as well as outpatients, is efficient 
from an economic perspective [66,67].  
5.2. Fortification of Affordable Products for Emerging Economies 
Micronutrient deficiency as well as undernutrition as a whole is a common public health problem in 
developing countries, especially for infants, young children, and women of reproductive age. In a recent 
systematic review and meta-analysis, the effects of micronutrient fortified milk and cereal food on the 
health of the younger age groups have been evaluated, using data from randomized controlled trials. In 
the Philippines, 36% of all children between the ages of 0.5–5 years, suffer from malnutrition and 
micronutrient deficiencies, resulting in costs from disease of approximately 1 billion USD. Compared 
to non-fortified food, iron plus multi-micronutrient fortification increases hemoglobin levels by  
0.87 g/dL and reduces risk of anemia by 57%. It was also found that iron plus multi-micronutrient-
fortification is more effective than iron only fortification for hematologic outcomes like hemoglobin 
levels. The study demonstrates that multi-nutrient fortified milk and cereal products are an effective 
option to reduce anemia in children up to 3 years of age in developing countries, resulting in a reduction 
of common morbidities in pre-school children. Reducing anemia by 50% would mean a GDP gain of 
0.2% (ca. 0.35 billion USD) or 4.5% of health costs in the Philippines [68]. This example clearly shows 
the benefits of improved early nutrition for the individuals and for the economies of their countries.  
6. Conclusions and Pending Issues to Reduce Health Care Costs 
Nutrition is very complex, as it comprises a mixture of nutrients acting in concert and dependent on 
one another. Nevertheless, a significant scientific and medical consensus exists about the importance of 
an appropriate level of macro- and micronutrient intake throughout the course of life to support growth, 
foster health, and prevent the onset of disease. Micronutrient requirements vary with the different stages 
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of life with adequate intakes having the highest impact during the first 1000 days of life. Later in life, 
micronutrient intake has to be adjusted to the specific requirements of the elderly and those living in 
particular settings such as hospitals and institutions. Other demographic groups are also at risk of nutrient 
deficiencies and inadequate intake, like pregnant and breastfeeding women, certain patient groups, and 
low-resource communities. Moreover, recent changes in life-style and eating patterns, along with 
increasing dependency on pre-cooked and processed foods, require more attention to nutrition as a key 
factor in determining human health. Appropriate micronutrient intake—as part of a balanced daily diet 
and in combination with a healthy lifestyle—supports health and well-being. The presence of 
undernutrition and micronutrient deficiencies in the developing world is well established, but a growing 
body of evidence indicates that micronutrient deficiencies also exist in the developed world, as does 
malnutrition, negatively affecting health, wellbeing, and economic status of significant sections of 
society. These nutritional deficiencies are often ignored and underappreciated despite being a global 
issue of rising importance with devastating consequences for individuals, communities and national 
economies. It is critical to continue developing nutritional solutions and economic models that address 
the value of nutrition interventions in improving public health as well as the impact thereof on health 
care budgets—evidence is very encouraging, however key stakeholders need to engage to make it happen. 
The extensive scientific knowledge currently available needs to be translated into cost-effective, 
practical public health solutions. These may include fortification and/or supplementation and specific 
delivery mechanisms should be assessed on a case-by-case basis. The health and economic benefits of 
fortification or supplementation with certain micronutrients—e.g., vitamin A (to reduce infant 
mortality), iodine (to reduce goiter), vitamin D (primarily against rickets), and folic acid (primarily to 
reduce neural tube defects)—as of medical nutrition are well-established. Many countries already have 
mandatory fortification programs in place regarding micronutrients. The absence of such programs in 
Europe (for folic acid and vitamin D) should be scrutinized in the light of the overwhelming evidence 
of the proven benefits of these fortification/supplementation programs. While the health and economic 
benefits of fortification or supplementation with vitamin D and folic acid are clear, more research is 
required in the context of other micronutrients. Micronutrient fortification and supplementation 
programs in the developing world should be scaled up to national level with the necessary support from 
donors. It is essential to give undernutrition the same high-level attention as is given to overnutrition and 
to translate existing evidence into public health actions. Malnutrition, meaning undernutrition in this 
article, is a major public health concern, mostly not visible in our increasingly overweight society but 
has serious health and economic consequences that cannot be ignored. The costs due to malnutrition in 
Europe exceed those related to obesity [69]: this will require public-private partnerships involving 
governments, academia, civil society and the private sector—four groups that have a key role in 
providing the necessary nutritional solutions (Figure 3). 
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Figure 3. Suggested strategic steps to reduce the burden of hidden hunger in  
developed countries 
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